Lipitor Lawsuit News: Bernstein Liebhard LLP Comments on Scheduling of Status Conference in Federal Lipitor Litigation

The Firm is representing a number of Lipitor lawsuit plaintiffs in federal court, all of whom allegedly developed Type 2 diabetes due to their use of the statin medication.

New York, New York (PRWEB) March 04, 2015

The federal litigation established for Lipitor lawsuits (http://www.lipitorlawsuitcenter.com/) that allege the statin drug caused patients to develop Type 2 diabetes continues to move forward in the U.S. District Court, District of South Carolina. According to court documents, the proceeding's next Status Conference will be convened on March 26, 2015 at 10:00 a.m. In advance of the Conference, the parties have been directed to submit a Joint Status report to the Court by March 19, 2015. (In re Lipitor (Atorvastatin) Litigation, MDL No. 2502)

"Our Firm is representing a number of Lipitor lawsuit plaintiffs whose claims are currently pending in federal court, and we are pleased to see this litigation progressing. We look forward to the March 26th Conference, as it will likely provide up-to-date information on the progress of discovery and other important developments in the proceeding," says Bernstein Liebhard LLP, a nationwide law firm representing victims of defective drugs and medical devices. The Firm is currently offering free and confidential case reviews to individuals who may have been harmed by Lipitor.

Lipitor Diabetes Allegations
Lipitor is a statin medications used in combination with diet and exercise to reduce levels of LDL or "bad" cholesterol. According to court documents, the U.S. Food & Drug Administration (FDA) announced in February 2012 that the labels for Lipitor and other statins would be updated to include new information about their potential association with Type 2 diabetes. The agency's announcement indicated that the label change was prompted by a review that included, among other things, a study published the previous month in JAMA: Internal Medicine which suggested that post-menopausal women treated with statins faced an increased risk of developing new-onset Type 2 diabetes. *

Court records indicate that more than 1,800 Lipitor lawsuits are now pending in the District of South Carolina, where all federally-filed claims that allege the drug increases the risk for Type 2 diabetes have been consolidated for coordinated pretrial proceedings. Among other things, plaintiffs accuse Pfizer Inc. of concealing the association between Lipitor and diabetes in order to protect sales of the drug. The lawsuits further allege that the label modifications made by Pfizer in 2012 still do not adequately address this risk, and assert that they would have never used the statin had they been aware of its association with diabetes.

Type 2 diabetes patients who allegedly developed the disease due to their use of Lipitor may be entitled to compensation for medical bills, lost wages, pain and suffering, and more. To learn more about filing a Lipitor lawsuit, please visit Bernstein Liebhard LLP's website. To arrange for a free case review, please call 800-511-5092.

*archinte.jamanetwork.com/article.aspx?articleid=1108676, JAMA Internal Medicine, January 23, 2012.

About Bernstein Liebhard LLP
Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993. As a national law firm, Bernstein Liebhard LLP possesses all of the legal and financial resources required to successfully challenge billion dollar pharmaceutical and medical device companies. As a result, our attorneys and legal staff have been able to recover more than $3 billion on behalf of our clients. The Firm has been named by The National Law Journal to the Plaintiffs' Hot List, recognizing the top plaintiffs firms in the country, for the past 12 consecutive years. Bernstein Liebhard LLP is the only firm in the country to be named to this prestigious list every year since it was first published in 2003.

Bernstein Liebhard LLP
10 East 40th Street
New York, New York 10016
800-511-5092

ATTORNEY ADVERTISING. © 2015 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, 800-511-5092. Prior results do not guarantee or predict a similar outcome with respect to any future matter.

Contact Information:
Sandy A. Liebhard, Esq.
Bernstein Liebhard LLP
info (at) consumerinjurylawyers (dot) com
http://www.lipitorlawsuitcenter.com/
https://plus.google.com/115936073311125306742?rel=author

For the original version on PRWeb visit: http://www.prweb.com/releases/lipitor-lawsuit/lipitor-diabetes/prweb12561950.htm